A cell-permeable, reversible, substrate competitive and potent p56lck tyrosine kinase inhibitor (IC50 = 18.5 µM). Selectively blocks the growth of v-ras transformed human bronchial epithelial cells (IC50 = 15 µM). Also suppresses HER2/neu tyrosine kinase activity in HER2/neu overexpressing breast cancer cells.
A cell-permeable, reversible, substrate competitive and potent p56lck tyrosine kinase inhibitor (IC50 = 18.5 µM). Selectively blocks the growth of v-ras transformed human bronchial epithelial cells (IC50 = 14.8 µM) without affecting normal human bronchial epithelial cells, even at a concentration of 370 mM. Reported to act as an inhibitor of Tau aggregation and aid in the disassembly of PHF in vitro and in vivo.
Biochem/physiol Actions
Cell permeable: yes
Primary Target p56lck tyrosine kinase
Product does not compete with ATP.
Reversible: yes
Target IC50: 18.5 µM against p56lck tyrosine kinase
Warning
Toxicity: Standard Handling (A)
Reconstitution
Following reconstitution in DMSO, aliquot and freeze (-20°C). DMSO stock solutions are stable for up to 3 months at -20°C. Unstable in aqueous alkali; reconstitute just prior to use.
Other Notes
Pickhardt, M., et al. 2004. J. Biol. Chem.280, 3628. Zhang, L., and Hung. M.C. 1996. Oncogene 12, 571. Chan, T.C., et al. 1993. Biochem. Biophys. Res. Commun. 193, 1152. Jayasuriya, H., et al. 1992. J. Nat. Prod.55, 696.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
